Χώρα: Νέα Ζηλανδία
Γλώσσα: Αγγλικά
Πηγή: Medsafe (Medicines Safety Authority)
Chlorphenamine maleate 2mg (from Compap CPM-0117); Paracetamol 500mg (319.08mg from Compap CPM-0117 + 180.92mg from Compap L-0093); ; Phenylephrine hydrochloride 5mg equivalent to 4.1 mg phenylephrine
Johnson & Johnson (New Zealand) Limited
Chlorphenamine maleate 2 mg (from Compap CPM-0117)
Tablet
Active: Chlorphenamine maleate 2mg (from Compap CPM-0117) Paracetamol 500mg (319.08mg from Compap CPM-0117 + 180.92mg from Compap L-0093) Phenylephrine hydrochloride 5mg equivalent to 4.1 mg phenylephrine Excipient: Crospovidone Balance of Compap L-0093 (maize starch, stearic acid, polyvinylpyrrolidone) Balance of Compap L-0117 (maize starch, stearic acid, polyvinylpyrrolidone) Silicified microcrystalline cellulose (98% microcrystalline cellulose BP, 2% silicon dioxide BP) Opadry orange 85F63129 Pregelatinised maize starch Purified water Stearic acid
Blister pack, PVD/PVDC film and Al foil, 12 tablets
Pharmacy only
Pharmacy only
Kongo Chemical Co., Ltd
Package - Contents - Shelf Life: Blister pack, PVD/PVDC film and Al foil - 12 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVD/PVDC film and Al foil - 24 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVD/PVDC film and Al foil - 36 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVD/PVDC film and Al foil - 48 tablets - 36 months from date of manufacture stored at or below 30°C
2008-05-05